Intended for healthcare professionals

Research Article

Clinical trial of mebendazole, a broad-spectrum anthelminthic.

Br Med J 1975; 2 doi: (Published 10 May 1975) Cite this as: Br Med J 1975;2:309
  1. J G Hutchison,
  2. N M Johnston,
  3. M V Plevey,
  4. I Thangkhiew,
  5. C Aidney


    Eighty-five children aged 5-14 years who were infested with worms were treated with mebendazole 100 mg twice daily for three days. The percentage cure rates were ascaris 100%, trichuris 94%, hookworm 82%, and hymenolepis 39%. The drug was well tolerated and with its broad activity should be very useful in treating those with multiple infestations.